
Bruker Corporation BRKR
$ 46.92
2.69%
Quarterly report 2026-Q1
added 05-07-2026
Bruker Corporation P/B Ratio 2011-2026 | BRKR
Annual P/B Ratio Bruker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.22 | 3.8 | 8.92 | 0.000011 | 0.000003 | 9.07 | 8.56 | 6.08 | 7.62 | 5.38 | 5.12 | 4.1 | 4.06 | 3.92 | 3.69 | 1.29 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.07 | 0.000003 | 4.62 |
P/B Ratio of other stocks in the Medical devices industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
9.9 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-0.418 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
4.95 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
0.168 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
52.1 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
0.204 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
7.5 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
11.3 | $ 11.82 | 3.32 % | $ 335 M | ||
|
Apollo Endosurgery
APEN
|
12.4 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
2.61 | $ 8.06 | -2.54 % | $ 1.21 B | ||
|
Aziyo Biologics
AZYO
|
-0.696 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
1.47 | $ 4.31 | 0.23 % | $ 161 M | ||
|
BioSig Technologies
BSGM
|
-5.13 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
0.098 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
0.233 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
2.36 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
13.4 | $ 2.3 | 0.44 % | $ 50.7 M | ||
|
CryoLife, Inc.
CRY
|
2.76 | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
3.37 | $ 1.04 | 2.97 % | $ 17.6 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.526 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
5.9 | $ 0.46 | 0.39 % | $ 28.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
1.26 | $ 17.9 | -2.56 % | $ 420 M | ||
|
Delcath Systems
DCTH
|
2.93 | $ 10.83 | -1.72 % | $ 388 M | ||
|
Soliton, Inc.
SOLY
|
7.38 | - | -1.42 % | $ 435 M | ||
|
LENSAR
LNSR
|
-5.83 | $ 6.05 | -0.66 % | $ 72.3 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
1.13 | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
3.17 | $ 75.42 | 2.15 % | $ 4.11 B | ||
|
Itamar Medical Ltd.
ITMR
|
7.86 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
1.26 | - | - | $ 462 M | ||
|
Pulmonx Corporation
LUNG
|
1.35 | $ 1.57 | 1.29 % | $ 63.9 M | ||
|
Neovasc
NVCN
|
13 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
0.598 | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
3.04 | $ 3.67 | 1.38 % | $ 542 M | ||
|
Electromed
ELMD
|
4.04 | $ 38.3 | 0.21 % | $ 324 M | ||
|
Myomo
MYO
|
2.97 | $ 1.03 | -0.96 % | $ 43.1 M | ||
|
Butterfly Network
BFLY
|
4.83 | $ 4.54 | 1.68 % | $ 1.12 B | ||
|
Intersect ENT, Inc.
XENT
|
11 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
12.8 | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
1.09 | $ 9.77 | -9.12 % | $ 387 M | ||
|
GBS
GBS
|
0.881 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
2.73 | $ 85.1 | 0.34 % | $ 11.5 B | ||
|
Profound Medical Corp.
PROF
|
2.5 | $ 6.77 | -0.88 % | $ 205 M | ||
|
Insulet Corporation
PODD
|
12 | $ 153.8 | -0.69 % | $ 10.8 B | ||
|
CONMED Corporation
CNMD
|
1.28 | $ 36.06 | -3.14 % | $ 1.12 B | ||
|
Sintx Technologies
SINT
|
2.36 | $ 2.43 | 1.67 % | $ 6.74 M | ||
|
Inspire Medical Systems
INSP
|
2.25 | $ 41.99 | -4.22 % | $ 1.23 B | ||
|
Integer Holdings Corporation
ITGR
|
1.7 | $ 90.14 | 0.96 % | $ 3.13 B | ||
|
Invacare Corporation
IVC
|
0.0313 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
4.72 | $ 87.54 | 2.05 % | $ 51.2 B | ||
|
TransMedics Group
TMDX
|
9.92 | $ 70.46 | 2.21 % | $ 2.4 B |